BRANCHPOINT BIOSCIENCES INC.

Biotech · Private

qPCR platform technology with proprietary software for designing discriminatory primers and probes to detect oral microbiome biomarkers from saliva samples

Grants
$409K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · A Comprehensive qPCR-Based Oral Microbiome Profiling Platform for Research and Discovery$409,403
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2437Palvella Therapeutics, Inc.—$63M
2438Tracon Pharmaceuticals, Inc.—$57M
2439VELOCITY LABORATORIES, LLC——
2440BRANCHPOINT BIOSCIENCES INC.——
2441SKROOT LABORATORY INC.——
2442PRECISION QUANTOMICS INC——
2443RHINO THERAPEUTICS INC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.